Cite
Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy.
MLA
Vanitha, Selvarajan, et al. “Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (HGM-CSF): Possibility of Nanoparticle-Mediated Delivery in Cancer Immunotherapy.” Bioengineered, vol. 8, no. 2, Mar. 2017, pp. 120–23. EBSCOhost, https://doi.org/10.1080/21655979.2016.1212136.
APA
Vanitha, S., Chaubey, N., Ghosh, S. S., & Sanpui, P. (2017). Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy. Bioengineered, 8(2), 120–123. https://doi.org/10.1080/21655979.2016.1212136
Chicago
Vanitha, Selvarajan, Nidhi Chaubey, Siddhartha S Ghosh, and Pallab Sanpui. 2017. “Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (HGM-CSF): Possibility of Nanoparticle-Mediated Delivery in Cancer Immunotherapy.” Bioengineered 8 (2): 120–23. doi:10.1080/21655979.2016.1212136.